Drug Type Small molecule drug |
Synonyms capridine beta, capridine beta(University of Gdansk/New York Medical College), Capridine-β + [2] |
Target |
Action inhibitors, modulators |
Mechanism CDK2 inhibitors(Cyclin-dependent kinase 2 inhibitors), CDK4 modulators(Cyclin-dependent kinase 4 modulators), CDK6 inhibitors(Cyclin-dependent kinase 6 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Preclinical | United States | 15 Apr 2012 | |
Prostatic Cancer | Preclinical | United States | 01 May 2005 | |
Prostatic Cancer | Preclinical | United States | 01 May 2005 | |
Prostatic Cancer | Preclinical | Poland | 01 May 2005 | |
Colonic Cancer | Discovery | United States | 21 Dec 2009 | |
Colonic Cancer | Discovery | Poland | 21 Dec 2009 |